Sullivan JA

References (4)

Title : Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study - Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755
Author(s) : Heller JH , Spiridigliozzi GA , Crissman BG , Sullivan JA , Eells RL , Li JS , Doraiswamy PM , Krishnan KR , Kishnani PS
Ref : J Child Adolesc Psychopharmacol , 16 :755 , 2006
Abstract : Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755
ESTHER : Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755
PubMedSearch : Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755
PubMedID: 17201619

Title : Donepezil use in Down syndrome -
Author(s) : Kishnani PS , Sullivan JA , Spiridigliozzi GA , Heller JH , Crissman BG
Ref : Archives of Neurology , 61 :605 , 2004
PubMedID: 15096417

Title : Donepezil for the treatment of language deficits in adults with Down syndrome: A preliminary 24-week open trial - Heller_2003_Am.J.Med.Genet_116_111
Author(s) : Heller JH , Spiridigliozzi GA , Sullivan JA , Doraiswamy PM , Krishnan RR , Kishnani PS
Ref : American Journal of Medicine Genet , 116 :111 , 2003
Abstract : Heller_2003_Am.J.Med.Genet_116_111
ESTHER : Heller_2003_Am.J.Med.Genet_116_111
PubMedSearch : Heller_2003_Am.J.Med.Genet_116_111
PubMedID: 12494428

Title : Cholinergic therapy for Down's syndrome -
Author(s) : Kishnani PS , Sullivan JA , Walter BK , Spiridigliozzi GA , Doraiswamy PM , Krishnan KR
Ref : Lancet , 353 :1064 , 1999
PubMedID: 10199357